Surrozen, Inc.
NEWS
Surrozen announced it paused its Phase I study in Crohn’s disease and ulcerative colitis as several healthy participants showed increased levels of liver enzymes.
Surrozen announced Thursday it has partnered with Boehringer Ingelheim to research and develop a therapeutic for the treatment of retinal diseases.
Closing out the month of May, plenty of companies presented or announced clinical trial updates and news. Here’s a look.
Surrozen’s ethos is “CLIMB ON”. This catchy and focus-appropriate acronym stands for Collaborate, Lead, Innovate, Motivate and be Brave, Open and Nurturing.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Investment funds continue springing up into life sciences companies across the globe. Here’s where the money’s being planted this week.
BioSpace is proud to present its NextGen “Class of 2018,” a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.
JOBS
IN THE PRESS